Medcura, Inc. — Form D
Medcura, Inc. of RIVERDALE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-16. The offering totals $5.6M, of which $3.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-08-16
- Form: D
- Accession: 0001567619-22-016358
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.6M
- Amount sold: $3.2M
- Remaining: $2.4M
- Investors: 26
- Date of first sale: 2022-07-29
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-456056
Issuer
- Name: Medcura, Inc.
- CIK: 0001672180
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 5650 RIVERTECH COURT, SUITE S, RIVERDALE, MD, 20737
- Phone: 3014053585
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Matthew Dowling | Director | Riverdale, MD |
| Matthew Dowling | Executive Officer | Riverdale, MD |
| Jim Buck | Director | Lakewood, WA |
| Jim Buck | Executive Officer | Lakewood, WA |
| Rich Vincent | Executive Officer | Riverdale, MD |
| Larry Tiffany | Director | Riverdale, MD |
| Larry Tiffany | Executive Officer | Riverdale, MD |
| Abbas Ardehali, M.D. | Director | Riverdale, MD |
| Matthew Dowling, Ph.D | Director | Riverdale, MD |
| Matthew Dowling, Ph.D | Executive Officer | Riverdale, MD |
| Alex Arrow | Director | Riverdale, MD |
| Peter Thomas | Director | Columbus, OH |
| Peter Thomas | Executive Officer | Columbus, OH |
Other filings by this issuer (8)
More